MedPath

Michael Dunbar

🇬🇧United Kingdom
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:3

Trial Phases

1 Phases

Not Applicable:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Not Applicable
2 (100.0%)

Simplex High Viscosity Bone Cement in Primary Total Knee Arthroplasty

Not Applicable
Completed
Conditions
Osteoarthritis
First Posted Date
2015-10-08
Last Posted Date
2021-08-09
Lead Sponsor
Michael Dunbar
Target Recruit Count
25
Registration Number
NCT02572310
Locations
🇨🇦

Nova Scotia Health Authority, Halifax, Nova Scotia, Canada

DePuy Attune Total Knee Arthroplasty RSA Study

Not Applicable
Completed
Conditions
Osteoarthritis
First Posted Date
2014-04-04
Last Posted Date
2019-02-01
Lead Sponsor
Michael Dunbar
Target Recruit Count
30
Registration Number
NCT02103504
Locations
🇨🇦

Concordia Hospital, Winnipeg, Manitoba, Canada

🇨🇦

Capital District Health Authority, Halifax, Nova Scotia, Canada

🇨🇦

Hopital Maisonneuve-Rosemont, Montreal, Quebec, Canada

Pilot Study Using Radiostereometric Analysis (RSA) to Evaluate the Fixation of the Tibial Components in the DePuy M.B.T. Revision Knee System

Completed
Conditions
Revision Total Knee Replacement
First Posted Date
2012-07-23
Last Posted Date
2019-01-31
Lead Sponsor
Michael Dunbar
Target Recruit Count
10
Registration Number
NCT01647386
Locations
🇨🇦

Capital District Health Authority, Halifax, Nova Scotia, Canada

News

No news found
© Copyright 2025. All Rights Reserved by MedPath